These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 10732528)

  • 21. [Should cases of hepatocellular carcinoma be discussed by non-specialized multidisciplinary team meetings?].
    Barbare JC; Franco D; André T; Bronowicki JP; Merle P; Péron JM; Raoul JL; Seitz JF; Ychou M
    Bull Cancer; 2014 Jun; 101(6):558-63. PubMed ID: 24898934
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Symptom management in hepatocellular carcinoma.
    Sun VC; Sarna L
    Clin J Oncol Nurs; 2008 Oct; 12(5):759-66. PubMed ID: 18842532
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multidisciplinary management of nonresectable hepatocellular carcinoma.
    Park HC; Seong J; Tanaka M; Zeng ZC; Lim HY; Guan S; Bae SH; Tak WY
    Oncology; 2011; 81 Suppl 1():134-40. PubMed ID: 22212947
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the survival and tolerability of radioembolization in elderly vs. younger patients with unresectable hepatocellular carcinoma.
    Golfieri R; Bilbao JI; Carpanese L; Cianni R; Gasparini D; Ezziddin S; Paprottka PM; Fiore F; Cappelli A; Rodriguez M; Ettorre GM; Saltarelli A; Geatti O; Ahmadzadehfar H; Haug AR; Izzo F; Giampalma E; Sangro B; Pizzi G; Notarianni E; Vit A; Wilhelm K; Jakobs TF; Lastoria S;
    J Hepatol; 2013 Oct; 59(4):753-61. PubMed ID: 23707371
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Building the multidisciplinary team for management of patients with hepatocellular carcinoma.
    Naugler WE; Alsina AE; Frenette CT; Rossaro L; Sellers MT
    Clin Gastroenterol Hepatol; 2015 May; 13(5):827-35. PubMed ID: 24909910
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Liver failure after transarterial chemoembolization for patients with hepatocellular carcinoma and ascites: incidence, risk factors, and prognostic prediction.
    Hsin IF; Hsu CY; Huang HC; Huang YH; Lin HC; Lee RC; Chiang JH; Lee FY; Huo TI; Lee SD
    J Clin Gastroenterol; 2011 Jul; 45(6):556-62. PubMed ID: 21666547
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High Prevalence of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Infection in Thailand.
    Wanich N; Vilaichone RK; Chotivitayatarakorn P; Siramolpiwat S
    Asian Pac J Cancer Prev; 2016; 17(6):2857-60. PubMed ID: 27356702
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trends in epidemiology, treatment, and survival of hepatocellular carcinoma patients between 1998 and 2009: an analysis of 1066 cases of a German HCC Registry.
    Weinmann A; Koch S; Niederle IM; Schulze-Bergkamen H; König J; Hoppe-Lotichius M; Hansen T; Pitton MB; Düber C; Otto G; Schuchmann M; Galle PR; Wörns MA
    J Clin Gastroenterol; 2014 Mar; 48(3):279-89. PubMed ID: 24045276
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Shaping the future management of hepatocellular carcinoma.
    Abou-Alfa G; Colombo M
    Semin Liver Dis; 2013 Feb; 33 Suppl 1():S20-3. PubMed ID: 23457036
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surgical resection and liver transplantation for hepatocellular carcinoma.
    Akoad ME; Pomfret EA
    Clin Liver Dis; 2015 May; 19(2):381-99. PubMed ID: 25921669
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multimodality treatment of hepatocellular carcinoma in a hepatobiliary specialty center.
    Marcos-Alvarez A; Jenkins RL; Washburn WK; Lewis WD; Stuart KE; Gordon FD; Kane RA; Clouse ME
    Arch Surg; 1996 Mar; 131(3):292-8. PubMed ID: 8611095
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Resectability of hepatocellular carcinoma: evaluation of 333 consecutive cases at a single hepatobiliary specialty center and systematic review of the literature.
    Sotiropoulos GC; Lang H; Frilling A; Molmenti EP; Paul A; Nadalin S; Radtke A; Brokalaki EI; Saner F; Hilgard P; Gerken G; Broelsch CE; Malagò M
    Hepatogastroenterology; 2006; 53(69):322-9. PubMed ID: 16795964
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A prospective longitudinal study of quality of life after resection of hepatocellular carcinoma.
    Poon RT; Fan ST; Yu WC; Lam BK; Chan FY; Wong J
    Arch Surg; 2001 Jun; 136(6):693-9. PubMed ID: 11387012
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Downstaging disease in patients with hepatocellular carcinoma outside of Milan criteria: strategies using drug-eluting bead chemoembolization.
    Green TJ; Rochon PJ; Chang S; Ray CE; Winston H; Ruef R; Kreidler SM; Glueck DH; Shulman BC; Brown AC; Durham J
    J Vasc Interv Radiol; 2013 Nov; 24(11):1613-22. PubMed ID: 24060436
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quality of Cancer Care in Patients with Cirrhosis and Hepatocellular Carcinoma.
    Dhanasekaran R; Talwalkar JA
    Curr Gastroenterol Rep; 2015 Sep; 17(9):34. PubMed ID: 26238927
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transcatheter arterial chemoembolization as primary treatment for hepatocellular carcinoma.
    Rose DM; Chapman WC; Brockenbrough AT; Wright JK; Rose AT; Meranze S; Mazer M; Blair T; Blanke CD; Debelak JP; Pinson CW
    Am J Surg; 1999 May; 177(5):405-10. PubMed ID: 10365881
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A Case of Hepatocellular Carcinoma with Lymph Node Metastasis Successfully Treated by Multidisciplinary Treatment].
    Soma D; Sakata J; Ando T; Yuza K; Ishikawa H; Ohashi T; Takizawa K; Takano K; Kobayashi T; Ichikawa H; Hanyu T; Nagahashi M; Shimada Y; Kameyama H; Wakai T
    Gan To Kagaku Ryoho; 2017 Nov; 44(12):1565-1567. PubMed ID: 29394703
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term effect of sustained virological response on hepatocellular carcinoma in patients with hepatitis C in Canada.
    Janjua NZ; Chong M; Kuo M; Woods R; Wong J; Yoshida EM; Sherman M; Butt ZA; Samji H; Cook D; Yu A; Alvarez M; Tyndall M; Krajden M
    J Hepatol; 2017 Mar; 66(3):504-513. PubMed ID: 27818234
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of early hepatocellular carcinoma in patients with well-compensated cirrhosis.
    Cunningham SC; Tsai S; Marques HP; Mira P; Cameron A; Barroso E; Philosophe B; Pawlik TM
    Ann Surg Oncol; 2009 Jul; 16(7):1820-31. PubMed ID: 19267161
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study.
    Park JW; Chen M; Colombo M; Roberts LR; Schwartz M; Chen PJ; Kudo M; Johnson P; Wagner S; Orsini LS; Sherman M
    Liver Int; 2015 Sep; 35(9):2155-66. PubMed ID: 25752327
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.